Maven Securities LTD Astrazeneca PLC Transaction History

Maven Securities LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $271,646 - $352,974	5,011 New	5,011 $339,000
Q2 2020 Aug 14, 2020	SELL	$43.1 - $55.31 $275,365 - $353,375	-6,389 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$40.12 - $45.47 $256,326 - $290,507	6,389 New	6,389 $290,000
Q2 2019 Aug 13, 2019	SELL	$37.28 - $41.68 $3.56 Million - $3.98 Million	-95,453 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$35.49 - $43.02 $3.39 Million - $4.11 Million	95,453 New	95,453 $3.88 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.